Ropeginterferon Alfa-2b (P1101) Phase 3 Study in Interferon Treatment-Naive Subjects With HCV Genotype 2 Infection

Clinical trial NCT04382937 · COMPLETED

Trial details

NCT number: NCT04382937
Sponsor: PharmaEssentia
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Hepatitis C Virus Infection

Start date: 2016-01-12
Primary completion: 2020-07-15
Enrollment: 222

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.